Choroidal vascularity index changes in different treatments for vitreomacular traction

Photodiagnosis Photodyn Ther. 2023 Dec:44:103741. doi: 10.1016/j.pdpdt.2023.103741. Epub 2023 Aug 11.

Abstract

Introduction: The aim of this study was to examine if choroidal vascularity index (CVI) is different in eyes with unilateral vitreomacular traction (VMT) from their healthy fellow eyes; and whether different treatments affect the CVI.

Methods: The baseline and 8-week post treatment CVIs of 56 unilateral VMT patients that underwent spontaneous resolution (n = 30), vitreoretinal surgery (n = 16) or pneumatic vitreolysis (n = 10) were compared with fellow eyes using paired samples t-test. Partial correlation analyses correcting age and gender was used for calculations between treatment groups. P values < 0.05 were considered statistically significant.

Results: The mean baseline CVI for VMT and control eyes had no statistically significant difference (p = 0.81, r= -0.38). The post traction release follow-up CVI of VMT eyes and contralateral eyes had no significant difference (p = 0.12, r = 0.49). In spontaneous resolution group, vitreoretinal surgery group and pneumatic vitreolysis group the baseline and follow up CVIs of VMT eyes were statistically similar (p = 0.72, p = 0.32 and p = 0.79 respectively).Spontaneous detachment patients' CVIs showed a 0.57±5.81% increase, vitreoretinal surgery group had a reduction of 1.098±4.76%, and the pneumatic vitreolysis patients showed a CVI reduction of 0.307±4.24%. However, none of these changes was found to be statistically significant when compared between the groups (p = 0.21, r = 0.02).

Discussion: Previous studies have argued that vitreomacular traction might have a role on the choroidal changes seen in the vitreoretinal interface disorders. This study has shown that VMT alone does not cause any significant changes in choroidal vascular index pre or post traction release.

Keywords: Choroidal vascularity index; OCT; Vitreolysis; Vitreomacular traction; Vitreoretinal surgery.

MeSH terms

  • Humans
  • Photochemotherapy* / methods
  • Photosensitizing Agents / therapeutic use
  • Retina
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Traction
  • Vitreous Detachment* / drug therapy
  • Vitreous Detachment* / surgery

Substances

  • Photosensitizing Agents